Consilium Scientific CEO

Leeza gained experience in academia, consulting and public sector before establishing Consilium Scientific in 2020.
Born in Russia, at the age of 15 she moved to the USA to study. After completing PhD in Systems Engineering, she came to England. Her career started at the University of Warwick Medical School where she worked as Senior Research Fellow on evaluating non-invasive foetal DNA tests. Then she relocated to London and joined a consulting company as a Principal Economist leading projects for NICE and other public sector departments. Leeza was a Director of NICE Scientific Advice between 2014 and 2018. In this capacity she chaired over 150 advisory meetings at NICE and at the EMA and provided methodological, operational, and strategic leadership for the team which became well-known internationally. During those years Leeza represented NICE as a chief analyst at the Department of Health Appraisal Alignment Working Group. Her academic work focuses on examining the status quo of clinical research, through quality improvement, transparency and methodological rigour. In particular, she is interested in clinical data integrity, health policy, applied clinical research, and clinical trial design. She is an expert in Health Technology Assessment and lectures at the Department of Health Policy at the London School of Economics.